GlassScriptPhysician profile
Florentino Robles
NPI 1245432723
$1,637.57
in general payments reported to CMS, 2019-2025
12 companies · $772 in 2025
The $772 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $14.96 · 2022: $80.34 · 2023: $348 · 2024: $422 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $318.24 | 2023-2024 | Injectafer |
| Abiomed | $194.41 | 2025 | |
| Novo Nordisk INC | $185.11 | 2022-2024 | Wegovy |
| Silk Road Medical, INC. | $145.38 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Lilly USA, LLC | $124.99 | 2025 | Mounjaro |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2025 | Airsupra |
| Biosense Webster, INC. | $121.53 | 2025 | Qdot Micro |
| Amgen INC. | $109.01 | 2025 | Krystexxa |
| Abbott Laboratories | $101.37 | 2023 | Freestyle Libre 3 |
| Abbvie INC. | $100.02 | 2024 | |
| Medtronic, INC. | $97.56 | 2025 | Closurefast |
| Sunovion Pharmaceuticals INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Florentino Robles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.